FindTrial
Sign In

The Impact of Adjuvant Therapy on Long-term Survival in Gallbladder Cancer Patients Treated with Curative-Intent Resection

The Impact of Adjuvant Therapy on Long-term Survival in Gallbladder Cancer Patients Treated with Curative-Intent Resection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096499
Enrollment
Unknown
Registered
2025-01-24
Start date
2025-01-27
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder cancer

Interventions

Adjuvant therapy group:with adjuvant therapy
Observation Group:Active monitoring and follow-up

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with gallbladder cancer Undergo radical resection for gallbladder cancer

Exclusion criteria

Exclusion criteria: 1.with neoadjuvant therapy; 2.with radiotherapy or targeted therapy; 3.death within 30 days postoperatively; 4.loss to follow-up; 5.missing baseline characteristics>10%; 6.with the resection of other organs, such as pancreaticoduodenectomy and gastrectomy.

Design outcomes

Primary

MeasureTime frame
Overall survival;Progression-free survival;—

Countries

China

Contacts

Public ContactZhiyu Chen

The First Affiliated Hospital of Army Medical University

chenzhiyu_umn@163.com+86 23 65460505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026